Vps34 Inhibitor (MD Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVps34 Inhibitor (MD Pharma)
Drug Alias NameMDP-050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3-kinase catalytic subunit type 3 inhibitors
TargetsPhosphatidylinositol 3-kinase catalytic subunit type 3
Therapy Area/IndicationsMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMD Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMD Pharma AB
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies

Other Information

ATC CodeN/A
Related LinksN/A